3 October 2025 in Cancer Research
FMS-like tyrosine kinase-3 internal tandem duplication (FLT3-ITD) mutations are frequent in acute myeloid leukemia (AML) and are associated with a high risk of relapse. CKLF-like MARVEL transmembrane domain containing member 6 (CMTM6) stabilizes PD-L1 surface expression and modulates tumor immunity in solid cancer. In this study, we found a role for FLT3-induced CMTM6 in hematologic malignancies. FLT3 drove CMTM6 and PD-L1 expression in AML cells, whereas FLT3 inhibition reduced expression of CMTM6 and PD-L1. In three distinct allogeneic hematopoietic cell transplantation mouse models, transplantation of Cmtm6-deficient FLT3-ITD+ leukemia cells resulted in prolonged survival, reduced leukemia burden, enhanced T-cell effector function, and decreased expression of T-cell exhaustion markers compared with Cmtm6-proficient FLT3-ITD+ leukemia cells. Furthermore, combination therapy with anti–PD-L1 and tandutinib significantly improved survival, suppressed leukemia cell expansion, and augmented the anti-leukemia T-cell response in mice bearing FLT3-ITD+ leukemia. Mechanistically, protein–protein interaction of FLT3 and CMTM6 within their transmembrane domains, which was not phosphorylation dependent, enhanced CMTM6 stability in leukemia cells, whereas FLT3-ITD did not increase CMTM6 and PD-L1 expression at the RNA level. Furthermore, CMTM6 upregulation and protein interaction with FLT3 were validated in primary leukemia cells from two independent cohorts of patients with FLT3-ITD+ AML. Collectively, these findings uncover FLT3-mediated stabilization of CMTM6 in AML cells, which results in enhanced PD-L1 cell surface expression and leukemia immune escape. Significance: Activation of the CMTM6/PD-L1 axis in FLT3-ITD–driven acute myeloid leukemia mediates immunosuppression, providing the basis for potential inhibition of this pathway to harness antitumor immunity.
29 July 2026 in Cell Death Discovery
During restricted timeframes in Drosophila development, re-replication occurs as physiological process causing the known developmental gene amplification in Drosophila . Gene amplification has also been found during differentiation in human stem cells but re-replication in human cells has been preferentially associated with tumor related genome instability. Here, we show that re-replication also occurs as physiological process in human stem cells. We used Rerep-Seq and fiber-combing to demonstrate re-replication during the differentiation of human myoblasts into myotubes and during the differentiation of mesenchymal stem cells into adipocytes, osteoblasts, chondrocytes, and neurons. Re-replication was detectable during specific timeframes in all differentiations analyzed. FACS sorting of re-replicating cells showed increased gene expression in re-replicated genome regions. Additionally, re-replicated DNA was identified as extranuclear DNA. This leads us to the hypothesis that cells that do not re-replicate and thus do not face an increased risk of chromosomal instability may ensure higher expression of certain genes and their encoded proteins during differentiation by incorporating re-replicated DNA from neighbouring cells with re-replication. We propose that human stem cells use an ancient re-replication mechanism to efficiently increase gene copy numbers, thereby meeting the heightened protein demands during differentiation.